William Blair & Company
PGEN icon

William Blair & Company’s Precigen PGEN Stock Holding History

William Blair & Company’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,393
Closed -$310K – 1232
2015
Q4 		$310K Buy
+10,393
New +$350K ﹤0.01% 947

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

William Blair & Company's PGEN Position: Q1 2016 in Review

William Blair & Company sold out of Precigen (PGEN) in Q1 2016, closing a stake of 10,393 shares — an estimated $310K sold.

William Blair & Company first reported a position in PGEN in Q4 2015 and held it in 1 quarter. The position peaked at $310K in Q4 2015. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • William Blair & Company reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • William Blair & Company sold 10,393 Precigen shares in Q1 2016, an estimated $310K.
  • William Blair & Company first reported a position in Precigen in Q4 2015 and held it in 1 quarter.
  • William Blair & Company's Precigen position peaked at $310K in Q4 2015.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on William Blair & Company's 13F filing for Q1 2016, filed 16 May 2016.